Xaira Therapeutics is listed on Rocketlist with 11 active roles. The company is categorized as AI-driven Drug Discovery in BioTech. Xaira Therapeutics is at Series D stage, with a B2B business model, headquartered in South San Francisco, United States. Xaira Therapeutics was founded in 2023 and has 191 employees. Xaira Therapeutics has raised $1B. Active roles are refreshed daily from public hiring sources.